High sustained virologic response rates in patients with chronic hepatitis C virus GT1, 2 or 3 infection following 16 weeks of MK-3682/grazoprevir/ruzasvir plus ribavirin after having failed 8 weeks of a triplet drug regimen (Part C of C-CREST-1 & 2)

Publikation: Forskning - peer reviewKonferenceabstrakt i tidsskrift

  • L. Serfaty
  • S. Pianko
  • Z Ben Ari
  • A. L. Laursen
  • Jesper Bach Hansen
  • E. J. Gane
  • H. C. Huang
  • Shidai Jin
  • J. Bourque
  • H. Liu
  • A. Grandhi
  • Mei Su
  • N. Gendrano
  • D. Fernsler
  • F. Dutko
  • B. Y. T. Nguyen
  • J. Wahl
  • E. Barr
  • W. Yeh
  • R. Plank
  • J. R. Butterton

Detaljer

OriginalsprogEngelsk
ArtikelnummerTHU-264
TidsskriftJournal of Hepatology
Vol/bind66
Tidsskriftsnummer1
Sider (fra-til)S306-S307
ISSN0168-8278
DOI
StatusUdgivet - 2017
Begivenhed The International Liver Congress / 52nd Annual meeting of the European Association for the Study of the Liver - Amsterdam, Holland

Konference

Konference The International Liver Congress / 52nd Annual meeting of the European Association for the Study of the Liver
LandHolland
ByAmsterdam
Periode19/04/201723/04/2017

Kort

ID: 260687650